Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors

Keyphrases

• Multiple Sclerosis Treatment 100%
• Oligodendrocyte Precursor Cells 100%
• Cerebrospinal Fluid 100%
• Transcriptional Changes 100%
• Patient-derived 100%
• Progressive multiple Sclerosis 83%
• Transcriptional Program 33%
• Transcriptional Response 33%
• Relapsing-remitting multiple Sclerosis 33%
• Western Blot 16%
• Human Brain 16%
• Gene Expression 16%
• Protein Level 16%
• Quantitative PCR 16%
• Adhesion Molecules 16%
• Cultured Cells 16%
• Treatment Group 16%
• Disease Course 16%
• Cellular Physiology 16%
• Disease Pathogenesis 16%
• Immunocytochemistry 16%
• Oligodendrocyte 16%
• Microarray Analysis 16%
• Oligodendrocyte Differentiation 16%
• Brain Parenchyma 16%
• Morphological Differentiation 16%
• Multiple Primary 16%
• Brain Ventricles 16%
• LGALS3 16%

Neuroscience

• Multiple Sclerosis 100%
• Primary Progressive Multiple Sclerosis 100%
• Oligodendrocyte Progenitor 100%
• Progenitor Cell 80%
• Relapsing Remitting Multiple Sclerosis 40%
• Oligodendrocyte 40%
• Gene Expression 20%
• Microarrays 20%
• Immunocytochemistry 20%
• Cell Adhesion Proteins 20%
• Parenchyma 20%
• Western Blotting 20%
• Reverse Transcription Polymerase Chain Reaction 20%